NeoChord announced that it appointed Todd Berg as its new CEO to oversee its programs for mitral valve repair. Minneapolis-based NeoChord develops technology for the delivery of artificial chords to treat mitral valve regurgitation. In the role, Berg oversees the clinical and commercial programs for the transeptal and transapical repair of damaged mitral valve chords. […]
NeoChord
NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
NeoChord appointed Dr. Martin Leon as executive chair of the company’s U.S. early feasibility study of its Transcatheter Nexus system. Leon will be responsible for overseeing and leading the company’s initiatives to advance its U.S. regulatory strategy for the Nexus system. He will also guide the company’s overall global regulatory strategy as it continues to […]